Aziyo Biologics to Present at the Cowen 43rd Annual Health Care Conference
February 27, 2023 08:15 ET
|
Aziyo Biologics
SILVER SPRING, Md., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between...
Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline Results
January 09, 2023 08:15 ET
|
Aziyo Biologics
SILVER SPRING, Md., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility...
Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
December 15, 2022 08:00 ET
|
Aziyo Biologics
Follows recent equity financing, resulting in debt and equity gross proceeds of $15.2 million SILVER SPRING, Md., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a...
Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock
December 01, 2022 09:04 ET
|
Aziyo Biologics
SILVER SPRING, Md., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility...
Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
November 30, 2022 16:08 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility...
Aziyo Biologics to Participate in Upcoming Investor Conferences
November 21, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a portfolio of regenerative products aimed at improving compatibility between...
Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
November 14, 2022 16:01 ET
|
Aziyo Biologics
Positive meeting with FDA provides clarity for CanGaroo® RM clearance SILVER SPRING, Md., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a...
Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022
November 07, 2022 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company with a portfolio of commercial therapies, today announced that it will...
Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors
October 24, 2022 08:00 ET
|
Aziyo Biologics
SILVER SPRING, Md., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company with a portfolio of commercial therapies, today announced the appointment...
Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets
October 11, 2022 16:35 ET
|
Aziyo Biologics
SILVER SPRING, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biological device company with a portfolio of commercial products across four distinct businesses, today...